Highest risk patients with clear-cell renal cell carcinoma benefit from adjuvant everolimus
A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell renal ...
Tag: Adjuvant
A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fourth leading cause of cancer-related mortality ...
MSD’s KEYTRUDA® (pembrolizumab) significantly improved disease-free survival (DFS) versus placebo as adjuvant therapy in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) regardless of PD-L1 expression
BRUSSELS; KENILWORTH, N.J., Mar. 17, 2022 – MSD, a trade name of Merck & Co., Inc, Kenilworth, NJ, USA., the ...
Adjuvant compared to early salvage therapy post prostatectomy in men with PN1 prostate cancer and decreased risk of mortality
Men with microscopic evidence of prostate cancer spreading to their pelvic lymph nodes (LNs) following the surgical resection of the ...
Adjuvant immunotherapy prolongs recurrence-free survival in resected stage II B/C melanoma
Lugano, Switzerland, 18 September 2021 – The first randomised phase III clinical trial in stage II melanoma has shown a 35% reduction in the risk of recurrence with adjuvant pembrolizumab compared with ...
-
Null results research now published by major behavioral medicine journal
-
How drugs can target the thick “scar tissue” of pancreatic cancer
-
‘Shocking’ discovery: Electricity from electric eels may transfer genetic material to nearby animals
-
Study identifies key ingredient for affordable fuel cell catalysts
-
Meteorites likely source of nitrogen for early Earth
-
Pivotal moment for humanity as tipping point threats and opportunities accelerate